3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
5
Phase 4
2
Phase NA
1
Phase 2
1
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Venous Thromboembolism
3
Neoplasms
3
Venous Thrombosis
2
Thrombosis
2
Pancreatic Neoplasms
2
Thromboembolism
1
Stomach Neoplasms
1
Pulmonary Embolism
1
Ovarian Neoplasms
1
Obesity
1
Multiple Myeloma
1
Gliosarcoma
1
Glioblastoma
1
Gastrointestinal Stromal Tumors
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Embolism and Thrombosis
1
Embolism
1
Duodenal Neoplasms
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Central Nervous System Neoplasms
1
Carcinoma, Hepatocellular
1
Biliary Tract Neoplasms
1
Interventions
apixaban
1
Tinzaparin
1
Heparin, Low-Molecular-Weight
1
Enoxaparin
1
Dalteparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Pulmonary Embolism
×
Dalteparin
×
Clear all
NCT01817257
2018-10-29
ALICAT
Cardiff University
Phase 2
Terminated
2 enrolled